vs
COMSTOCK RESOURCES INC（CRK）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
COMSTOCK RESOURCES INC的季度营收约是Royalty Pharma plc的1.3倍（$787.3M vs $622.0M），COMSTOCK RESOURCES INC净利率更高（35.7% vs 34.4%，领先1.2%），COMSTOCK RESOURCES INC同比增速更快（114.3% vs 4.8%），过去两年COMSTOCK RESOURCES INC的营收复合增速更高（53.1% vs 4.6%）
Comstock Resources Inc.是一家独立能源企业，主要从事天然气、原油及天然气凝液的勘探、开发、生产与销售业务，核心运营资产位于美国得州和路易斯安那州的页岩产区，服务北美能源市场。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CRK vs RPRX — 直观对比
营收规模更大
CRK
是对方的1.3倍
$622.0M
营收增速更快
CRK
高出109.5%
4.8%
净利率更高
CRK
高出1.2%
34.4%
两年增速更快
CRK
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $787.3M | $622.0M |
| 净利润 | $280.9M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 48.3% | 62.4% |
| 净利率 | 35.7% | 34.4% |
| 营收同比 | 114.3% | 4.8% |
| 净利润同比 | 583.3% | 2.9% |
| 每股收益（稀释后） | $0.99 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRKRPRX
| Q4 25 | $787.3M | $622.0M | ||
| Q3 25 | $449.9M | $609.3M | ||
| Q2 25 | $470.3M | $578.7M | ||
| Q1 25 | $512.9M | $568.2M | ||
| Q4 24 | $367.4M | $593.6M | ||
| Q3 24 | $304.5M | $564.7M | ||
| Q2 24 | $246.8M | $537.3M | ||
| Q1 24 | $335.8M | $568.0M |
净利润CRKRPRX
| Q4 25 | $280.9M | $214.2M | ||
| Q3 25 | $111.1M | $288.2M | ||
| Q2 25 | $124.8M | $30.2M | ||
| Q1 25 | $-121.3M | $238.3M | ||
| Q4 24 | $-58.1M | $208.2M | ||
| Q3 24 | $-28.9M | $544.0M | ||
| Q2 24 | $-126.3M | $102.0M | ||
| Q1 24 | $-16.3M | $4.8M |
营业利润率CRKRPRX
| Q4 25 | 48.3% | 62.4% | ||
| Q3 25 | 11.2% | 70.1% | ||
| Q2 25 | 19.0% | 36.3% | ||
| Q1 25 | 24.6% | 94.0% | ||
| Q4 24 | -0.5% | 60.9% | ||
| Q3 24 | -20.1% | — | ||
| Q2 24 | -37.5% | 50.2% | ||
| Q1 24 | -3.8% | -13.0% |
净利率CRKRPRX
| Q4 25 | 35.7% | 34.4% | ||
| Q3 25 | 24.7% | 47.3% | ||
| Q2 25 | 26.5% | 5.2% | ||
| Q1 25 | -23.6% | 41.9% | ||
| Q4 24 | -15.8% | 35.1% | ||
| Q3 24 | -9.5% | 96.3% | ||
| Q2 24 | -51.2% | 19.0% | ||
| Q1 24 | -4.9% | 0.8% |
每股收益（稀释后）CRKRPRX
| Q4 25 | $0.99 | $0.49 | ||
| Q3 25 | $0.40 | $0.67 | ||
| Q2 25 | $0.44 | $0.07 | ||
| Q1 25 | $-0.40 | $0.55 | ||
| Q4 24 | $-0.19 | $0.46 | ||
| Q3 24 | $-0.09 | $1.21 | ||
| Q2 24 | $-0.43 | $0.23 | ||
| Q1 24 | $-0.05 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.9M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.6B | $9.7B |
| 总资产 | $7.0B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CRKRPRX
| Q4 25 | $23.9M | $618.7M | ||
| Q3 25 | $19.2M | $938.9M | ||
| Q2 25 | $25.9M | $631.9M | ||
| Q1 25 | $32.9M | $1.1B | ||
| Q4 24 | $6.8M | $929.0M | ||
| Q3 24 | $13.8M | $950.1M | ||
| Q2 24 | $19.3M | $1.8B | ||
| Q1 24 | $6.4M | $843.0M |
总债务CRKRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益CRKRPRX
| Q4 25 | $2.6B | $9.7B | ||
| Q3 25 | $2.4B | $9.6B | ||
| Q2 25 | $2.2B | $9.5B | ||
| Q1 25 | $2.1B | $9.8B | ||
| Q4 24 | $2.2B | $10.3B | ||
| Q3 24 | $2.3B | $10.3B | ||
| Q2 24 | $2.3B | $9.8B | ||
| Q1 24 | $2.4B | $9.9B |
总资产CRKRPRX
| Q4 25 | $7.0B | $19.6B | ||
| Q3 25 | $6.8B | $19.3B | ||
| Q2 25 | $6.7B | $18.3B | ||
| Q1 25 | $6.6B | $17.6B | ||
| Q4 24 | $6.4B | $18.2B | ||
| Q3 24 | $6.3B | $18.0B | ||
| Q2 24 | $6.3B | $17.7B | ||
| Q1 24 | $6.3B | $16.1B |
负债/权益比CRKRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $224.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-141.2M | — |
| 自由现金流率自由现金流/营收 | -17.9% | — |
| 资本支出强度资本支出/营收 | 46.4% | — |
| 现金转化率经营现金流/净利润 | 0.80× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-449.7M | — |
8季度趋势，按日历期对齐
经营现金流CRKRPRX
| Q4 25 | $224.2M | $827.1M | ||
| Q3 25 | $153.1M | $702.6M | ||
| Q2 25 | $347.6M | $364.0M | ||
| Q1 25 | $174.7M | $596.1M | ||
| Q4 24 | $267.1M | $742.5M | ||
| Q3 24 | $98.2M | $703.6M | ||
| Q2 24 | $83.6M | $658.2M | ||
| Q1 24 | $171.5M | $664.6M |
自由现金流CRKRPRX
| Q4 25 | $-141.2M | — | ||
| Q3 25 | $-188.4M | — | ||
| Q2 25 | $3.2M | — | ||
| Q1 25 | $-123.2M | — | ||
| Q4 24 | $-12.9M | — | ||
| Q3 24 | $-131.1M | — | ||
| Q2 24 | $-153.2M | — | ||
| Q1 24 | $-179.9M | — |
自由现金流率CRKRPRX
| Q4 25 | -17.9% | — | ||
| Q3 25 | -41.9% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | -24.0% | — | ||
| Q4 24 | -3.5% | — | ||
| Q3 24 | -43.1% | — | ||
| Q2 24 | -62.1% | — | ||
| Q1 24 | -53.6% | — |
资本支出强度CRKRPRX
| Q4 25 | 46.4% | — | ||
| Q3 25 | 75.9% | — | ||
| Q2 25 | 73.2% | — | ||
| Q1 25 | 58.1% | — | ||
| Q4 24 | 76.2% | — | ||
| Q3 24 | 75.3% | — | ||
| Q2 24 | 95.9% | — | ||
| Q1 24 | 104.7% | — |
现金转化率CRKRPRX
| Q4 25 | 0.80× | 3.86× | ||
| Q3 25 | 1.38× | 2.44× | ||
| Q2 25 | 2.78× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRK
| Other | $420.7M | 53% |
| Natural Gas And Oil Sales | $366.6M | 47% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
